Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are between 50 and 80 years old at the time of signing up for the trial.
- People who meet at least one of the following smoking history requirements: smoked at least 20 pack-years and currently smoke or stopped within the last 15 years; OR smoked for at least 20 years regardless of how much they smoked; OR smoked at least 20 pack-years with no restriction on how long ago they quit.
- People who are already receiving or are scheduled to receive a low-dose CT (LDCT) lung scan through the UI Health Lung Screening Program.
- People who are willing to watch a short educational video (about 2 minutes) about AI-assisted lung screening, complete a related survey if selected, and optionally provide a blood sample.
- People who are able to sign a consent form and authorise the release of their personal health information as required by the trial.
- Women who could potentially become pregnant must not currently be pregnant or breastfeeding, and a pregnancy test will be required.
- People who, in the opinion of the enrolling doctor, are able to understand and follow the study procedures for the full duration of the trial.
Who may not be able to join:
- People who are unable to have a low-dose CT (LDCT) lung scan.
- People who currently have lung cancer or have been diagnosed with lung cancer within the last 5 years.
- People whose life expectancy is less than 1 year.
- People who currently have an active lung infection that requires treatment with systemic medication (such as antibiotics taken by mouth or through a drip).
- People in vulnerable groups, including prisoners and women who are pregnant or breastfeeding, due to the radiation involved in the LDCT scan.
- People with other serious health conditions, as determined by the study's lead doctor.
- People who have a mental or physical condition that prevents them from giving informed consent or taking part in the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mary Pasquinelli, DNP, University of Illinois at Chicago
Phone: (312) 996-8039
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Expanded screening eligibility with Sybil AI risk scoring; Sybil AI performance in USPSTF-eligible participants; Combined biomarker, Sybil AI, and Brock model risk stratification
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.